litlas
ログインアカウント作成

David L. Swerdlow

1992–2024 年に発表

別表記
David L Swerdlow
107
論文数
27,427
被引用数
79
h 指数
107
i10 指数

被引用数

David L. Swerdlow の年別被引用数1982 年: 被引用 1 件1989 年: 被引用 1 件1992 年: 被引用 2 件1993 年: 被引用 7 件1994 年: 被引用 9 件1995 年: 被引用 15 件1996 年: 被引用 12 件1997 年: 被引用 16 件1998 年: 被引用 29 件1999 年: 被引用 46 件2000 年: 被引用 46 件2001 年: 被引用 80 件2002 年: 被引用 94 件2003 年: 被引用 99 件2004 年: 被引用 108 件2005 年: 被引用 120 件2006 年: 被引用 154 件2007 年: 被引用 128 件2008 年: 被引用 133 件2009 年: 被引用 145 件2010 年: 被引用 229 件2011 年: 被引用 221 件2012 年: 被引用 172 件2013 年: 被引用 165 件2014 年: 被引用 141 件2015 年: 被引用 209 件2016 年: 被引用 174 件2017 年: 被引用 171 件2018 年: 被引用 117 件2019 年: 被引用 408 件2020 年: 被引用 1,033 件2021 年: 被引用 912 件2022 年: 被引用 644 件2023 年: 被引用 334 件2024 年: 被引用 385 件2025 年: 被引用 165 件2026 年: 被引用 6 件1983〜1988 年は被引用が無いため表示していません1990〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,984 件、この内訳の 29.9%イギリス: 引用元論文 697 件、この内訳の 7%中国: 引用元論文 606 件、この内訳の 6.1%カナダ: 引用元論文 352 件、この内訳の 3.5%イタリア: 引用元論文 345 件、この内訳の 3.5%フランス: 引用元論文 339 件、この内訳の 3.4%ドイツ: 引用元論文 301 件、この内訳の 3%オーストラリア: 引用元論文 243 件、この内訳の 2.4%インド: 引用元論文 243 件、この内訳の 2.4%スペイン: 引用元論文 222 件、この内訳の 2.2%オランダ: 引用元論文 179 件、この内訳の 1.8%韓国: 引用元論文 165 件、この内訳の 1.7%
0%29.9%その他 33.1%

機関

分野

  • Medicine52.3%
  • Biochemistry, Genetics and Molecular Biology16.2%
  • Agricultural and Biological Sciences7.9%
  • Immunology and Microbiology6.8%
  • Mathematics5.3%
  • Environmental Science2.4%
  • その他9.1%

トピック

  • SARS-CoV-2 and COVID-19 Research6.8%
  • COVID-19 Clinical Research Studies5.4%
  • COVID-19 epidemiological studies4.2%
  • Viral gastroenteritis research and epidemiology4%
  • Respiratory viral infections research3.8%
  • Influenza Virus Research Studies3.7%
  • その他72.1%

共著者

全論文

検索で開く
  1. Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis

    著者: John M. McLaughlin, Farid Khan, Elizabeth Begier, David L. Swerdlow, Luis Jódar, Ann R. Falsey - Open Forum Infectious Diseases 2022 被引用: 214

  2. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

    著者: Eric J. Haas, Frederick J. Angulo, John M. McLaughlin, Emilia Anis, Shepherd Roee Singer, Farid Khan, Nati Brooks, Meir Smaja, Gabriel Mircus, Kaijie Pan, Jo Southern, David L. Swerdlow, Luis Jódar, Yeheskel Levy, Sharon Alroy‐Preis - The Lancet 2021 被引用: 1,751

  3. Respiratory Syncytial Virus–Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis

    著者: John M. McLaughlin, Farid Khan, Heinz‐Josef Schmitt, Yasmeen Agosti, Luis Jódar, Eric A. F. Simões, David L. Swerdlow - The Journal of Infectious Diseases 2020 被引用: 114

  4. The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis

    著者: Myint Tin Tin Htar, Manasa Shanta Yerramalla, Jennifer C. Moïsi, David L. Swerdlow - Epidemiology and Infection 2020 被引用: 149

  5. An open challenge to advance probabilistic forecasting for dengue epidemics

    著者: Michael A. Johansson, Karyn M. Apfeldorf, Scott Dobson, Jason P. DeVita, Anna L. Buczak, Benjamin Baugher, Linda Moniz, Thomas Bagley, Steven M. Babin, Erhan Guven, Teresa K. Yamana, Jeffrey Shaman, Terry Moschou, Nick Lothian, Aaron Lane, Grant Osborne, Gao Jiang, Logan Brooks, David Farrow, Sangwon Hyun, Ryan J. Tibshirani, Roni Rosenfeld, Justin Lessler, Nicholas G Reich, Derek A. T. Cummings, Stephen A. Lauer, Sean M. Moore, Hannah Clapham, Rachel Lowe, Trevor Bailey, Markel García‐Díez, Marília Sá Carvalho, Xavier Rodó, Tridip Sardar, Richard Paúl, Evan L Ray, Krzysztof Sakrejda, Alexandria Brown, Xi Meng, Osonde Osoba, Raffaele Vardavas, David Manheim, Melinda Moore, Dhananjai M. Rao, Travis C. Porco, Sarah F. Ackley, Fengchen Liu, Lee Worden, Matteo Convertino, Yang Liu, Abraham Reddy, Eloy Ortiz, Jorge Rivero, Humberto Brito, Alicia Juarrero, Leah R. Johnson, Robert B. Gramacy, Jeremy M. Cohen, Erin A. Mordecai, Courtney C. Murdock, Jason R. Rohr, Sadie J. Ryan, Anna M. Stewart‐Ibarra, Daniel P. Weikel, Antarpreet Jutla, Rakibul Khan, Marissa Poultney, Rita R. Colwell, Brenda Rivera-García, Christopher M. Barker, Jesse E. Bell, Matthew Biggerstaff, David L. Swerdlow, Luis Mier-y-Terán-Romero, Brett M. Forshey, J. Trtanj, Jason Asher, Matthew Clay, Harold S. Margolis, Andrew M. Hebbeler, Dylan B. George, Jean-Paul Chrétien - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 被引用: 238

  6. Epidemiology ofEscherichia coliO157:H7 Outbreaks, United States, 1982–2002

    著者: Josefa M. Rangel, P.H. Sparling, Collen Crowe, Patricia M. Griffin, David L. Swerdlow - Emerging infectious diseases 2005 被引用: 1,264

  7. Botulinum Toxin as a Biological Weapon

    著者: S. S. Arnon, Robert Schechter, Thomas V. Inglesby, Donald A. Henderson, John G. Bartlett, Michael S. Ascher, Edward M. Eitzen, Anne D. Fine, Jerome Hauer, Marcelle Layton, Scott R. Lillibridge, Michael T. Osterholm, Tara O’Toole, Gerald Parker, Trish M. Perl, Philip K. Russell, David L. Swerdlow, Kevin Tonat, for the Working Group on Civilian Biodefense - JAMA 2001 被引用: 1,805

  8. Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009

    著者: Seema Jain, Laurie Kamimoto, Anna M. Bramley, Ann Schmitz, Stephen R. Benoit, Janice K. Louie, David Sugerman, Jean K. Druckenmiller, Kathleen A. Ritger, Rashmi Chugh, Supriya Jasuja, Meredith Deutscher, Sanny Chen, John D. Walker, Jeffrey S. Duchin, Susan Lett, Susan Soliva, Eden V. Wells, David L. Swerdlow, Timothy M. Uyeki, Anthony E. Fiore, Sonja J. Olsen, Alicia M. Fry, Carolyn B. Bridges, Lyn Finelli - New England Journal of Medicine 2009 被引用: 1,715

  9. Epidemiology of Seafood-Associated Infections in the United States

    著者: Martha Iwamoto, Tracy Ayers, Barbara E. Mahon, David L. Swerdlow - Clinical Microbiology Reviews 2010 被引用: 587

  10. Rocky Mountain Spotted Fever from an Unexpected Tick Vector in Arizona

    著者: Linda J. Demma, Marc Traeger, William L. Nicholson, Christopher D. Paddock, Dianna M. Blau, Marina E. Eremeeva, Gregory A. Dasch, Michael L. Levin, Joseph Singleton, Sherif R. Zaki, James E. Cheek, David L. Swerdlow, Jennifer H. McQuiston - New England Journal of Medicine 2005 被引用: 463

  11. Acute otitis media, antimicrobial prescriptions, and medical expenses among children in the United States during 2011–2016

    著者: Jose A Suaya, Bradford D. Gessner, Shirley Fung, Scott Vuocolo, John Scaife, David L. Swerdlow, Raúl Istúriz, Adriano Arguedas - Vaccine 2018 被引用: 83

  12. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

    著者: Karen L. Kotloff, Jonathan P. Winickoff, B Ivanoff, John D. Clemens, David L. Swerdlow, Philippe Sansonetti, Goutam K. Adak, Myron M. Levine - 1999 被引用: 1,264

  13. H1N1 2009 influenza virus infection during pregnancy in the USA

    著者: Denise J. Jamieson, Margaret A. Honein, Sonja A. Rasmussen, Jennifer L. Williams, David L. Swerdlow, Matthew Biggerstaff, Stephen Lindstrom, Janice K. Louie, Cara Christ, Susan Bohm, Vincent P. Fonseca, Kathleen A. Ritger, Daniel Kuhles, Paula Eggers, Hollianne Bruce, Heidi A Davidson, Emily Lutterloh, Meghan L. Harris, Colleen M. Burke, Noelle M. Cocoros, Lyn Finelli, Kitty MacFarlane, Bo Shu, Sonja J. Olsen - The Lancet 2009 被引用: 1,381

  14. Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2

    著者: Manuela Di Fusco, Mary M. Moran, Alejandro Cané, Daniel Curcio, Farid Khan, Deepa Malhotra, Andy Surinach, Amanda Miles, David L. Swerdlow, John M. McLaughlin, Jennifer L. Nguyen - Journal of Medical Economics 2021 被引用: 57

  15. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study

    著者: Eric J. Haas, John M. McLaughlin, Farid Khan, Frederick J. Angulo, Emilia Anis, Marc Lipsitch, Shepherd Roee Singer, Gabriel Mircus, Nati Brooks, Meir Smaja, Kaijie Pan, Jo Southern, David L. Swerdlow, Luis Jódar, Yeheskel Levy, Sharon Alroy‐Preis - The Lancet Infectious Diseases 2021 被引用: 135

  16. Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017

    著者: Charles Nuttens, Jamie Findlow, Paul Balmer, David L Swerdlow, Myint Tin Tin Htar - Eurosurveillance 2022 被引用: 35

  17. Defining the Epidemiology of Covid-19 — Studies Needed

    著者: Marc Lipsitch, David L. Swerdlow, Lyn Finelli - New England Journal of Medicine 2020 被引用: 1,354

  18. Estimating the Burden of 2009 Pandemic Influenza A (H1N1) in the United States (April 2009-April 2010)

    著者: Sundar S. Shrestha, David L. Swerdlow, Rebekah H. Borse, Vimalanand S. Prabhu, L. Finelli, Charisma Y. Atkins, Kwame Owusu‐Edusei, Beth P. Bell, Paul S. Mead, Matthew Biggerstaff, Lynnette Brammer, Harriet Davidson, Daniel B. Jernigan, Michael A. Jhung, Laurie Kamimoto, Toby L. Merlin, Mackenzie Nowell, Stephen C. Redd, Carrie Reed, Anne Schuchat, Martin I. Meltzer - Clinical Infectious Diseases 2010 被引用: 451

  19. A Change in Vaccine Efficacy and Duration of Protection Explains Recent Rises in Pertussis Incidence in the United States

    著者: Manoj Gambhir, Thomas A. Clark, Simon Cauchemez, Sara Y. Tartof, David L. Swerdlow, Neil M. Ferguson - PLoS Computational Biology, PLoS Comput. Biol. 2015 被引用: 123

  20. Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: A systematic review and pooled analysis

    著者: John M. McLaughlin, Qin Jiang, Bradford D. Gessner, David L. Swerdlow, Heather L. Sings, Raúl Istúriz, Luis Jódar - Vaccine 2019 被引用: 57

  21. Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014

    著者: Dianna Ng, Farida Al Hosani, M. Kelly Keating, Susan I. Gerber, Tara L. Jones, Maureen G. Metcalfe, Suxiang Tong, Ying Tao, Negar Niki Alami, Lia M. Haynes, Mowafaq Ali Mutei, Laila AbdelWareth, Timothy M. Uyeki, David L. Swerdlow, Maha T Barakat, Sherif R. Zaki - American Journal Of Pathology 2016 被引用: 401

  22. Estimates of the Prevalence of Pandemic (H1N1) 2009, United States, April–July 2009

    著者: Carrie Reed, Frederick J. Angulo, David L. Swerdlow, Marc Lipsitch, Martin I. Meltzer, Daniel B. Jernigan, Lyn Finelli - Emerging infectious diseases 2009 被引用: 363

  23. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design

    著者: John M. McLaughlin, Qin Jiang, Raúl Istúriz, Heather L. Sings, David L. Swerdlow, Bradford D. Gessner, Ruth Carrico, Paula Peyrani, Timothy L. Wiemken, William A. Mattingly, Julio A. Ramírez, Luis Jódar - Clinical Infectious Diseases 2018 被引用: 161

  24. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys

    著者: Frederick J. Angulo, Lyn Finelli, David L. Swerdlow - JAMA Network Open 2021 被引用: 153